We discovered that the hepatitis B vaccine not only activates B lymphocytes to produce anti-HBs but may also promote the activation and proliferation of CD8+ T lymphocytes directly or indirectly via anti-HBs, all of which aid the body’s eventual clearance of HBV. This evidence concerns the gene CD8A and hepatitis A virus infection.